Research

Hydration and N-acetyl-l-cysteine alter the microstructure of human nail and bovine hoof: implications for drug delivery


Reference:

Nogueiras-Nieto, L., Gómez-Amoza, J. L., Delgado-Charro, M. B. and Otero-Espinar, F. J., 2011. Hydration and N-acetyl-l-cysteine alter the microstructure of human nail and bovine hoof: implications for drug delivery. Journal of Controlled Release, 156 (3), pp. 337-344.

Related documents:

[img]
Preview
PDF (DelgardoCharro_JCR_2011.pdf) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (11MB) | Preview

    Official URL:

    http://dx.doi.org/10.1016/j.jconrel.2011.08.021

    Abstract

    This work aimed to (a) characterize the microstructure and porosity of human nail and bovine hoof by mercury intrusion porosimetry and SEM image analysis, (b) study the effects of hydration and of N-acetyl-l-cysteine treatment on the microstructure of both membranes, and (c) determine whether the microstructural modifications were associated with changes in drugpenetration measured by standard diffusion studies. Bovine hoof surface is more porous than nail surface although there were no differences between the mean surface pore sizes. Hydration and N-acetyl-l-cysteine increased the roughness and apparent surface porosity, and the porosity determined by mercury intrusion porosimetry of both membranes. Pore-CorTM was used to generate tridimensional structures having percolation characteristics comparable to nail and hooves. The modeled structures were horizontally banded having an inner less-porous area which disappeared upon treatment. Treatment increased the predicted permeability of the simulated structures. Triamcinolone permeation increased significantly for hooves treated N-acetyl-l-cysteine, i.e., the membranes for which microstructural and permeability changes were the largest. Thus, microstructural changes determined via mercury intrusion porosimetry and subsequently modeled by Pore-CorTM were related to drug diffusion. Further refinement of the technique will allow fast screening of penetration enhancers to be used in ungual drug delivery.

    Details

    Item Type Articles
    CreatorsNogueiras-Nieto, L., Gómez-Amoza, J. L., Delgado-Charro, M. B. and Otero-Espinar, F. J.
    DOI10.1016/j.jconrel.2011.08.021
    DepartmentsFaculty of Science > Pharmacy & Pharmacology
    Publisher StatementDelgardoCharro_JCR_2011.pdf: NOTICE: this is the author’s version of a work that was accepted for publication in Journal of Controlled Release. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Controlled Release, vol 156, issue 3, 2001 DOI 10.1016/j.jconrel.2011.08.021
    RefereedYes
    StatusPublished
    ID Code25664

    Export

    Actions (login required)

    View Item

    Document Downloads

    More statistics for this item...